Friday 23 September
Please find below the programme schedule for Thursday 23 September 2022.
Meet the experts session 2
M2.1 Point of care test
Cornelia Lass Flörl, Austria and Martin Hönigl, Austria
08:00
M2.2 Allergic fungal lung diseases
Ritesh Agarwal, India and Koichiro Asano, Japan
09:00
Key note (P6) New azoles in management of invasive mould infections
Johan Maertens, Belgium
Parallel session 7
Parallel session 7 will take place from 10:30 hrs. until 12:00 hrs. and consists of five symposia.
S7.1 Update in management of fungal infection in adult haematology
Chair: Xiao-Jun Huang, China
10:30
S7.1a Update in prophylaxis
Livio Pagano, Italy
10:50
S7.1b Breakthrough fungal infection
Dinesh Bhurani, India
11:10
S7.1c New treatment options for management of fungal infections
Johan Maertens, Belgium
11:30
S7.1d Reliability of bedside point-of-care tests for C. neoformans, M. tuberculosis and S. pneumoniae in adults living with HIV presenting with suspected central nervous system infection (CNS) in low- and middle-income settings: Preliminary results from the DREAMM study
Aude Sturny Leclere, France
11:45
Q&A with all speakers
S7.2 More than just candidemia: Clinical aspects, diagnosis and treatment, and pathogenesis of deep- seated candidiasis
Chair: TBD
10:30
S7.2a Non- bloodstream deep-seated candidiasis: Clinical spectrum of disease, epidemiology and antifungal resistance
M. Hong Nguyen, USA
10:50
S7.2b Advances in the diagnosis, treatment and prevention of deep-seated candidiasis
Ram Gopalakrishnan, India
11:10
S7.2c Candida- host interactions and pathogenesis of deep-seated candidiasis, and lessons for patient management
Rajeev Soman, India
11:30
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis
Xiaodong She, China
11:45
Q&A with all speakers
S7.3 Emergent theories on pathogenic fungal dispersal around the globe
Chair: Jianping Xu, Canada
10:30
S7.3a Emergence and dispersal of Coccidioides in the Western Hemisphere
David Engelthaler, USA
10:50
S7.3b Niche and dispersal of Candida auris
Wieland Meyer, Australia
11:10
S7.3c Evolution of Pseudogymnoascus destructans, the cause of white nose syndrome in bats
Jianping Xu, Canada
11:30
S7.3d Environmental Surveillance of Aspergillus fumigatus in Dutch agricultural crops
Jianhua Zhang, Netherlands
11:45
Q&A with all speakers
S7.4 Pathgenesis and host defense
Chairs: Shibuya Kazutoshi, Japan and Shigeru Kohno, Japan
10:30
S7.4a Vaccine-inducing lung resident CD4+ memory T cells are protective against Cryptococcus gattii infections
Keigo Ueno, Japan
10:50
S7.4b Microaerobic conditions enhance fungal pathogenesis in Candida spp.
Yoshitsugu Miyazaki, Japan
11:10
S7.4c The hidden pathophysiology behind the images of invasive fungal infections
Kazutoshi Shibuya, Japan
11:30
S7.4d Candida albicans SR-like protein kinases regulate different cellular processes: Sky1 is involved in control of ion homeostasis, while Sky2 is important for dipeptide utilization
Philipp Brandt, Germany
11:45
Q&A with all speakers
S7.5 Late breaking abstracts
TBD
12:00
Lunch and poster session 3
12:30
Pipeline lunch session
Key note (P7): Banging our head against the (fungal) wall
Neil Gow, UK
Parallel sessions 8
Parallel session 8 will take place from 15:00 hrs. until 16:30 hrs. and consists of five symposia.
S8.1 Tackling Candida auris in resource-limited settings
Chairs: Nelesh Govender, South-Africa and Methee Chayakulkeeree, Thailand
15:00
S8.1a Something along the lines of “A global update on Candida auris’
Tom Chiller, USA
15:20
S8.1b Emergence and establishment of C. auris in Indian hospitals
Anuradha Chowdhary, India
15:40
S8.1c Is a search and destroy strategy still feasible for Candida auris in South Africa?
Nelesh Govender, South-Africa
16:00
S8.1d Innovative approaches to tackle C. auris in Latin America
Arnaldo Lopes Colombo, Brazil
16:15
Q&A with all speakers
S8.2 What is new in pediatric mycology?
Chair: Emmanuel Roilides, Greece
15:00
S8.2a Trends in epidemiology of pediatric Candida infections worldwide
Emmanuel Roilides, Greece
15:20
S8.2b Aspergillus spp. in primary immunodeficiencies and cystic fibrosis
Adilia Warris, UK
15:40
S8.2c Updated guidelines in the management invasive fungal infections in paediatrics
Andreas Groll, Germany
16:00
S8.2d Fungal beta-glucans and mannan performances in HIV-associated histoplasmosis
Antoine Adenis, France
16:15
Q&A with all speakers
S8.3 How the Fungal Cell Wall Glycan Can Modulate the Immune Response?
Chair: Boualem Sendid, France
15:00
S8.3a Structural aspects
TBD
15:20
S8.3b How Fungal Cell Wall Glycans Modulate the Activation of Platelets?
Samir Jawhara, France
15:40
S8.3c Cell wall glycans as targets for the development of new antifungals
Vishukumar Aimanianda, France
16:00
S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: role in pathogenicity
Rupinder Kaur, India
16:15
Q&A with all speakers
S8.4 Veterinary Mycology and One Health Working Group Business Meeting
Chairs : Jacques Guillot, France and Amir Seyedmousavi, USA
S8.5 Genotyping of Cryptococcus neoformans and C. gattii
Chairs: Wieland Meyer, Australia and Carolina Firacative, Colombia
15:00
S8.5a The global MLST database and it use in characterising the population structure of the Cryptococcus neoformans and C. gattii species complexes
Wieland Meyer, Australia
15:20
S8.5b Molecular Epidemiology of the C. neoformans and C. gattii species complexes in India
Ferry Hagen, Netherlands
15:40
S8.5c MLST Genotyping and phylogenetics of AD-hybrids
Massimo Cogliati, Italy
16:00
S8.5d Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Colombia develop heteroresistance to fluconazole at high concentrations
Carolina Firacative, Colombia
16:15
Q&A with all speakers
16:30
Break
Parallel session 9
Parallel session 9 will take place from 16:45 hrs. until 18:15 hrs. and consists of five symposia.
S9.1 Chronic Pulmonary Aspergillosis - where do we stand?
Chair: Aleksandra Barac, Serbia
16:45
S9.1a Diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis
Malcolm Ricardson, UK
17:05
S9.1b Clinical presentations and complications of chronic pulmonary aspergillosis
Aleksandra Barac, Serbia
17:25
S9.1c Current treatment options for CPA and future directions
David Denning, UK
17:45
S9.1d Chronic pulmonary aspergillosis in post-tb and retreatment tb patients in Lagos, Nigeria
Adeyinka Davies, Nigeria
18:00
Q&A with all speakers
S9.2 Azole resistance in Aspergillus fumiagatus: how hot is your hotspot?
Jianhua Zhang, Netherlands and Paul Verweij, Netherlands
16:45
S9.2a Hotspots of AMR in A. fumigatus; sex, drugs & (re) evolution
Jianhua Zhang, Netherlands
17:05
S9.2b Hot and Cold: the expanding distribution of triazole-resistance in Aspergillus fumigatus
Jianping Xu, UK
17:25
S9.2c A genomic approach to unravel the origin & spread of azole-resistant A. fumigatus
TBD
17:45
S9.2d Directed evolution of voriconazole resistance in Aspergillus fumigatus identifies novel mutations responsible for triazole resistance
Nir Osherov, Israel
18:00
Q&A with all speakers
S9.3 Drug resistance in emerging pathogenic fungi
Chairs: Rajendra Prasad, India and Kaustuv Sanyal, India
16:45
S9.3a Antifungal resistance in emerging Candida auris
Jeffrey Rybak, Germany
17:05
S9.3b Fighting drug resistance with immunotherapies: Update on the Candida vaccine project
Ashraf Ibrahim, USA
17:25
S9.3c Antifungal drug resistance in clinical isolates of Candida spp: behind the curtains
Dominique Sanglard, France
17:45
S9.3d Antivirulence drug discovery to disarm Candida albicans with metabolites from myxobacteria
Raghav Vij, Germany
S9.4 Free oral paper session
Chair: TBD
16:45
S9.4a TBD
17:05
S9.4b TBD
17:25
S9.4c TBD
17:45
S9.4d TBD
18:00
Q&A with all speakers
S9.5 Malassezia: pathogenesis and disease
Chair: Thomas Dawson, Singapore
16:45
S9.5a Role of Malassezia in Crohns disease and IBD
TBD
17:05
S9.5b The need for longitudinal testing in human disease
TBD
17:25
S9.5c Malassezia/Host interactions and the Il-17/23 axis
Salomé LeibundGut- Landmann, Switzerland
17:45
S9.5d Genotyping of Malassezia species from seborrheic dermatitis/dandruff patients
Prasanna Honnavar, Canada
18:00
Q&A with all speakers
19:30
Congress dinner